N. Vandeghinste

853 total citations
15 papers, 586 citations indexed

About

N. Vandeghinste is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, N. Vandeghinste has authored 15 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Dermatology. Recurrent topics in N. Vandeghinste's work include Dermatology and Skin Diseases (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Systemic Lupus Erythematosus Research (2 papers). N. Vandeghinste is often cited by papers focused on Dermatology and Skin Diseases (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Systemic Lupus Erythematosus Research (2 papers). N. Vandeghinste collaborates with scholars based in Belgium, Germany and Netherlands. N. Vandeghinste's co-authors include Reginald Brys, L. Lepescheux, Joost J. van den Oord, C. De Wolf‐Peeters, Marc De Ley, Steve De Vos, René Galien, Jean H.M. Feyen, Béatrice Vayssière and L Nelles and has published in prestigious journals such as The Journal of Immunology, Annals of the Rheumatic Diseases and Journal of Investigative Dermatology.

In The Last Decade

N. Vandeghinste

13 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Vandeghinste Belgium 9 182 170 154 139 117 15 586
W. Nürnberg Germany 12 208 1.1× 53 0.3× 175 1.1× 121 0.9× 90 0.8× 27 536
Thomas Pap Switzerland 6 246 1.4× 144 0.8× 191 1.2× 238 1.7× 45 0.4× 7 689
Pei Qiao China 13 229 1.3× 69 0.4× 369 2.4× 120 0.9× 155 1.3× 30 685
Lars Hummerich Germany 6 271 1.5× 138 0.8× 345 2.2× 64 0.5× 151 1.3× 6 654
Alejandro Morales United States 12 170 0.9× 77 0.5× 121 0.8× 123 0.9× 151 1.3× 27 640
Joanna Boncela Poland 19 363 2.0× 165 1.0× 105 0.7× 55 0.4× 35 0.3× 43 755
Karolina Przybyłowska Poland 17 379 2.1× 241 1.4× 88 0.6× 43 0.3× 64 0.5× 48 828
Patrice Boissy Denmark 12 332 1.8× 223 1.3× 51 0.3× 43 0.3× 37 0.3× 16 636
Yale Liu China 15 163 0.9× 47 0.3× 228 1.5× 110 0.8× 143 1.2× 41 558
Myung-Shin Jeon United States 9 232 1.3× 142 0.8× 480 3.1× 156 1.1× 21 0.2× 10 795

Countries citing papers authored by N. Vandeghinste

Since Specialization
Citations

This map shows the geographic impact of N. Vandeghinste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Vandeghinste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Vandeghinste more than expected).

Fields of papers citing papers by N. Vandeghinste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Vandeghinste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Vandeghinste. The network helps show where N. Vandeghinste may publish in the future.

Co-authorship network of co-authors of N. Vandeghinste

This figure shows the co-authorship network connecting the top 25 collaborators of N. Vandeghinste. A scholar is included among the top collaborators of N. Vandeghinste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Vandeghinste. N. Vandeghinste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Anquetil, Florence, Roland Blanqué, Daisy Liekens, et al.. (2025). GLPG2737, a CFTR Inhibitor, Prevents Cyst Growth in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease. American Journal of Nephrology. 56(6). 1–17.
2.
Riet, Sander van, Annemarie van Schadewijk, Steve De Vos, et al.. (2020). Modulation of Airway Epithelial Innate Immunity and Wound Repair by M(GM-CSF) and M(M-CSF) Macrophages. Journal of Innate Immunity. 12(5). 410–421. 16 indexed citations
3.
Lauffer, Felix, Manja Jargosch, Linda Krause, et al.. (2019). IL‐17C amplifies epithelial inflammation in human psoriasis and atopic eczema. Journal of the European Academy of Dermatology and Venereology. 34(4). 800–809. 35 indexed citations
4.
Vandeghinste, N., Florence Marsais, Jan D. Haas, et al.. (2018). Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis. Journal of Investigative Dermatology. 138(7). 1555–1563. 94 indexed citations
5.
Dupont, Sonia, Ingrid Arijs, Roland Blanqué, et al.. (2015). GPR84 inhibition as a novel therapeutic approach in IBD: mechanistic and translational studies. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
6.
Vanhoutte, Frédéric, Sonia Dupont, Roland Blanqué, et al.. (2015). P612. Human safety, pharmacokinetics and pharmacodynamics of the GPR84 antagonist GLPG1205, a potential new approach to treat IBD.. Journal of Crohn s and Colitis. 9(suppl 1). S387–S387. 3 indexed citations
7.
Rompaey, Luc Van, René Galien, Ellen M. van der Aar, et al.. (2013). Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases. The Journal of Immunology. 191(7). 3568–3577. 181 indexed citations
8.
Vayssière, Béatrice, Steve De Vos, Marielle Auberval, et al.. (2013). THU0116 Biological Effects of the JAK1 Selective Inhibitor GLPG0634 on Inflammation Markers in Arthritic Mice. Annals of the Rheumatic Diseases. 72. A201–A202.
9.
Jacques, Peggy, Jens Van Praet, Michael Drennan, et al.. (2010). A multiparameter approach to monitor disease activity in collagen-induced arthritis. Arthritis Research & Therapy. 12(4). R160–R160. 61 indexed citations
10.
Maanen, Marjolein A. van, Susanne P. Stoof, Esmerij P. van der Zanden, et al.. (2009). The α7 nicotinic acetylcholine receptor on fibroblast‐like synoviocytes and in synovial tissue from rheumatoid arthritis patients: A possible role for a key neurotransmitter in synovial inflammation. Arthritis & Rheumatism. 60(5). 1272–1281. 66 indexed citations
11.
Vandeghinste, N., et al.. (2000). Metallothionein isoform gene expression in zinc-treated human peripheral blood lymphocytes.. PubMed. 46(2). 419–33. 16 indexed citations
12.
Oord, Joost J. van den, N. Vandeghinste, Marc De Ley, & C. De Wolf‐Peeters. (1994). Bcl-2 expression in human melanocytes and melanocytic tumors.. PubMed. 145(2). 294–300. 86 indexed citations
13.
Beele, Hilde, et al.. (1993). [Pretibial epidermolysis bullosa: a study in a family with lichenoid lesions].. PubMed. 120(11). 771–4. 5 indexed citations
14.
Vandeghinste, N., J. De Bersaques, M. L. Geerts, & A Kint. (1992). Acitretin as Cancer Chemoprophylaxis in a Renal Transplant Recipient. Dermatology. 185(4). 307–308. 19 indexed citations
15.
Vandeghinste, N., Jean Naeyaert, M. L. Geerts, & A Kint. (1992). [Acute hemorrhagic edema in an infant].. PubMed. 43(12). 786–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026